H40.62X2 Glaucoma secondary to drugs, left eye, moderate stage

Name of the Condition

• Glaucoma Secondary to Drugs, Left Eye, Moderate Stage

Summary

Glaucoma secondary to drugs, left eye, moderate stage, is a condition where increased intraocular pressure (IOP) or optic nerve damage in the left eye results from the use of certain medications. This form of glaucoma may develop due to the pharmacological effects of drugs on the eye’s drainage structures or optic nerve, potentially leading to vision loss if not identified and managed promptly. The moderate stage indicates measurable structural or functional changes in the left eye.

Causes

The condition arises when medications disrupt the left eye’s normal fluid drainage or damage the optic nerve. Common mechanisms include drugs that alter the trabecular meshwork, reduce aqueous humor outflow, or directly affect optic nerve health. Examples include corticosteroids, certain antidepressants, and some anticholinergic agents, which can elevate IOP or cause optic nerve changes over time.

Risk Factors

• Prolonged use of corticosteroid medications (topical, inhaled, or systemic).
• Use of drugs known to affect intraocular pressure (e.g., some anticholinergics, antipsychotics).
• Pre-existing ocular conditions that increase susceptibility to drug-induced pressure changes.
• Genetic predisposition to steroid responsiveness.

Symptoms

• Elevated intraocular pressure (detected via tonometry) in the left eye.
• Gradual vision changes, such as blurred or reduced peripheral vision.
• Possible optic nerve damage visible on examination.
• Eye discomfort or pain (less common in moderate stages).

Diagnosis

Diagnosis involves a comprehensive eye examination, including tonometry to measure IOP, visual field testing to assess optic nerve function, and imaging (e.g., optical coherence tomography) to evaluate optic nerve structure. A detailed medication history is critical to identify potential drug-induced causes. The moderate stage is determined by the extent of structural or functional changes observed.

Treatment Options

Treatment focuses on managing IOP and addressing the underlying drug cause. Options may include discontinuing or adjusting the offending medication, topical or oral medications to lower IOP, and in some cases, laser therapy or surgery to improve aqueous humor outflow. Regular monitoring is essential to track progression.

Prognosis and Follow-Up

With appropriate management, vision loss may be slowed or prevented. Follow-up typically includes regular IOP checks, visual field testing, and optic nerve imaging to assess stability. Adherence to treatment and medication adjustments is key to maintaining eye health.

Complications

Untreated or poorly managed moderate glaucoma can progress to severe vision loss or blindness. Other complications include optic nerve atrophy and irreversible visual field defects.

Lifestyle & Prevention

• Avoid or limit use of medications known to elevate IOP, when possible.
• Regular eye exams, especially for those on long-term drug therapy.
• Promptly report any vision changes to a healthcare provider.

When to Seek Professional Help

Seek care if you experience new or worsening vision changes, eye pain, or persistent elevated IOP readings. Early intervention is critical to prevent progression.

Tips for Medical Coders

Document the specific stage (moderate) and laterality (left eye) clearly. Include details on the causative drug(s) and any diagnostic findings supporting the moderate stage to ensure accurate code assignment.